Aurobindo Pharma

Aurobindo Pharma receives US FDA approval for allergic conjunctivitis solution

The approved product has an estimated market size of $235 million

Aurobindo Pharma gets USFDA nod for its conjunctivitis drug

The company has received final approval from the United States Food & Drug Administration (USFDA) to manufacture and market Olopatadine Hydrochloride Ophthalmic Solution USP in the strength of 0.1 per cent

Aurobindo Pharma receives USFDA approval for methylprednisolone sodium succinate injection

The approved product has an estimated market size of $102 million for the twelve months ending October 2015 according to IMS Aurobindo Pharma has received final approval from the US Food & Drug Administration (US FDA) to

Aurobindo Pharma shares gain on USFDA approval for diarrhoea, allergy drugs

At 1:39 pm, the shares of Aurobindo Pharma were trading 1.76 per cent up at Rs 834.75 on BSE, while on NSE, the scrip gained 1.68 per cent at Rs 834.25. Sensex was up 0.14 per cent at 25,530.96.

aurobindo

Sensex, Nifty to make flat-to-cautious start on GST woes; Aurobindo Pharma, Biocon in focus today

The BSE Sensex and NSE Nifty are likely to open on a soft-to-cautious note on Thursday tracking SGX Nifty

sks microfinance share price, Sensex, NIfty, BSE, NSE

12 stocks that made news today: Jet Airways, Punj Lloyd, Dena Bank and more

Jet Airways shares ended 5.93 per cent up at Rs 440.35 after the company said it will acquire 75 fuel-efficient 737 MAX 8 aircraft from US plane maker Boeing.

Jet airways

Aurobindo Pharma may launch Tramadol tablets in US market

Aurobindo Pharma today said it may launch Tramadol Hydrochloride extended-release tablets, used for treating pain, in the US market from January.

aurobindo pharma, bse sensex

Aurobindo Pharma receives US FDA approval for tramadol hydrochloride extended-release tabs

Tramadol hydrochloride tabs are used in the treatment of moderate-to-severe pain in adults Aurobindo Pharma has received final approval from the US Food & Drug Administration (US FDA) to manufacture and market tramadol hy

Aurobindo Pharma receives US FDA Approval for Alzheimer’s drug

The approved product has an estimated market size of $1.23 billion according to IMS Aurobindo Pharma has received the final approval from the US Food & Drug Administration (US FDA) to manufacture and market memantine hydr

Aurobindo Pharma’s Telangana unit gets nod from green panel

Based on the recommendations of the Expert Appraisal Committee (EAC), the ministry gave final green nod to the ‘A’ category projects Environment Ministry’s green panel EAC has approved drug maker Aurobindo P

Rosier year-end seen for Lupin, Aurobindo, Glenmark thanks to faster US approvals

India's pharmaceutical industry is expected to see sales and profit growth accelerate in the second half of the year, thanks to a pickup in the pace of U.S. approvals for new drugs, offsetting any downturn in volatile emergin

Aurobindo gets USFDA nod for generic hypertension tablets

Aurobindo Pharma has received final approval from US health regulator to make and sell in America the generic Telmisartan tablets used for treating hypertension.

aurobindo pharma, bse sensex

Aurobindo Pharma receives US FDA approval for Telmisartan tabs

Telmisartan tablets are indicated in the treatment of essential hypertension

Aurobindo Pharma shares gain over 3% on key drug approvals

Aurobindo Pharma shares over 3 per cent in the early trade on Monday on BSE after the company on August 29 said it has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Ralox

aurobindo pharma, bse sensex

ARBN top pick on strong pace of approvals: Citigroup

After a light FY15, ARBN has received 15 approvals in FY16 YTD. This is a mix of plain-vanilla and limited competition products.

Aurobindo Pharma gets USFDA nod for hepatitis B drug

Aurobindo Pharma has received approval from the US health regulator to market generic Entecavir tablets, used to treat hepatitis B, in the American market.

aurobindo pharma, bse sensex

Aurobindo gets US FDA nod for hepatitis B drug

Entecavir tablets are indicated for treatment of chronic hepatitis B virus infection of the liver Aurobindo Pharma has received approval from the US health regulator to market generic Entecavir tablets, used to treat hepatiti

Aurobindo Pharma receives US FDA approval for Omeprazole delayed-release capsules

Omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults

Aurobindo Pharma posts Rs 3320.4-crore total operating income at Q1/FY2015-16

Profit after tax after minority interest was at Rs 432.4 crores Aurobindo Pharma has posted the unaudited consolidated financial highlights for Q1 FY2015-16. Total operating income was up by 14.1 per cent to Rs 3320.4 crores.

Aurobindo Pharma Q1 net profit up 4% at Rs 432 crore

Aurobindo Pharma today reported a 4.1 per cent increase in its net profit at Rs 432.4 crore during the first quarter ended June 30, 2015.

Aurobindo Pharma receives US FDA approval for Esmolol Hydrochloride injection

Esmolol Hydrochloride injection is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation Aurobindo Pharma has received final approvals from the US Food &amp

Aurobindo Pharma receives approval for Azithromycin for injection and Entacapone tabs

Azithromycin for injection is indicated for treatment of patients with community-acquired pneumonia and pelvic inflammatory disease

Aurobindo Pharma gets US FDA nod for extended phenytoin sodium capsules

Phenytoin sodium extended capsules is an anti-epileptic product and indicated for the control of seizures and prevention and treatment of seizures occurring during or following neurosurgery

Aurobindo Pharma receives USFDA approval for Metronidazole tablets

Metronidazole tablets are used to treat different types of infections

Aurobindo Pharma posts Q4/FY2014-15 results

Total operating income was up by 35.7 per cent to Rs 3162.1 crores in Q4 FY2014-15 Aurobindo Pharma has posted its Q4/FY2014-15 results. In Q4 FY2014-15, the total operating income was up by 35.7 per cent to Rs 3162.1 crores

Pharmexcil organises series of initiatives during CPhI Japan

Brand India Pharma was strongly represented by Indian pharma companies at various platforms

Cabinet clears Rs 4,187-crore Glenmark, Aurobindo proposals

The decision was taken by CCEA, chaired by Prime Minister Narendra Modi

Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Most Read

Advertisement

Top News

Advertisement

Related Articles